Ian Ying Woo Exercises Options at NovaBridge Biosciences (NBP) — SEC Form 4, Oct 19, 2026

SEC Form 4 · No Market Transaction
Option Exercise

Derivative exercise — no open market transaction.

Reporting Owner
Director
TXN 2026-10-15 · FILED 2026-10-19
Equity Position 13.3K sh 0 → 13,271
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-10-19
Report Date
2026-10-19
Accession No.
0002115245-26-000004
Accepted At
2026-10-19 20:15 UTC
Reporting Owner
Name Relationship
Ian Ying Woo CIK 0002115245
Director
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary SharesF1F2F3F2 2026-10-15 M - Exercise 13,271 A — 13,271 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Restricted Share UnitsF3F4F5F5F1F6F6 2026-10-15 M - Exercise 5,770 D $0.00 5,770 Ordinary Shares Direct
Footnotes (6)
F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
F2
Reported securities are represented by 5,770 ADSs. Show more
F3
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
F4
Reported securities represent ADSs. Show more
F5
On October 15, 2025, the Reporting Person was granted 17,310 restricted share units ("RSUs"). The RSUs vest or shall vest over three years in equal annual installments on October 15, 2026, 2027 and 2028. Show more
F6
Reported securities represent ADSs. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at NovaBridge Biosciences
All NovaBridge Biosciences insider activity
GET /v1/forms/4/0002115245-26-000004 API docs
View Original SEC Filing